Avoro Capital Advisors as of Sept. 30, 2019
Portfolio Holdings for Avoro Capital Advisors
Avoro Capital Advisors holds 33 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 12.2 | $292M | 3.8M | 77.91 | |
| Immunomedics | 11.6 | $279M | 21M | 13.26 | |
| Iovance Biotherapeutics (IOVA) | 8.1 | $193M | 11M | 18.20 | |
| Ascendis Pharma A S (ASND) | 7.9 | $190M | 2.0M | 96.32 | |
| BioMarin Pharmaceutical (BMRN) | 6.8 | $164M | 2.4M | 67.40 | |
| Amarin Corporation (AMRN) | 5.4 | $129M | 8.5M | 15.16 | |
| Sarepta Therapeutics (SRPT) | 5.3 | $126M | 1.7M | 75.32 | |
| Horizon Therapeutics | 4.5 | $109M | 4.0M | 27.23 | |
| Argenx Se (ARGX) | 4.0 | $95M | 835k | 113.96 | |
| Amicus Therapeutics (FOLD) | 3.7 | $89M | 11M | 8.02 | |
| Myokardia | 3.4 | $81M | 1.6M | 52.15 | |
| Zogenix | 3.1 | $75M | 1.9M | 40.04 | |
| Athenex | 3.0 | $72M | 5.9M | 12.17 | |
| Tricida | 2.8 | $68M | 2.2M | 30.87 | |
| Pacira Pharmaceuticals (PCRX) | 2.5 | $61M | 1.6M | 38.07 | |
| Karyopharm Therapeutics (KPTI) | 2.4 | $58M | 6.1M | 9.62 | |
| Global Blood Therapeutics In | 2.0 | $49M | 1.0M | 48.52 | |
| ACADIA Pharmaceuticals (ACAD) | 1.3 | $32M | 888k | 35.99 | |
| BioDelivery Sciences International | 1.3 | $31M | 7.4M | 4.21 | |
| Madrigal Pharmaceuticals (MDGL) | 1.3 | $31M | 360k | 86.22 | |
| Allogene Therapeutics (ALLO) | 1.3 | $31M | 1.1M | 27.26 | |
| Adverum Biotechnologies | 1.0 | $23M | 4.3M | 5.45 | |
| Ptc Therapeutics I (PTCT) | 1.0 | $23M | 684k | 33.82 | |
| Xenon Pharmaceuticals (XENE) | 0.9 | $22M | 2.4M | 9.01 | |
| Medicines Company | 0.8 | $19M | 372k | 50.00 | |
| Uniqure Nv (QURE) | 0.6 | $14M | 365k | 39.36 | |
| Cymabay Therapeutics | 0.6 | $14M | 2.7M | 5.12 | |
| Kodiak Sciences (KOD) | 0.3 | $7.2M | 500k | 14.38 | |
| Fennec Pharmaceuticals (FENC) | 0.2 | $5.3M | 1.1M | 4.81 | |
| Teligent | 0.2 | $5.0M | 5.2M | 0.95 | |
| Turning Point Therapeutics I | 0.2 | $3.8M | 100k | 37.60 | |
| Alimera Sciences | 0.1 | $3.6M | 6.2M | 0.57 | |
| Rocket Pharmaceuticals (RCKT) | 0.1 | $3.3M | 286k | 11.65 |
